Brolucizumab

Uses

Brolucizumab is used in the treatment of wet age-related macular degeneration.

How it Works

How Brolucizumab works Vascular endothelial growth factor (VEGF) is a protein that promotes the growth of new blood vessels. In certain eye diseases, abnormal blood vessels begin to grow under the retina, leading to fluid leakage, bleeding, and damage to the central part of the retina known as the macula. This can result in severe vision loss and distortion of central vision. Brolucizumab blocks the activity of the VEGF protein. By inhibiting VEGF, the medication reduces the growth and leakage of abnormal blood vessels in the retina.

Side Effects

Common side effects of Brolucizumab include retinal hemorrhage, uveitis, eye pain, reduced visual acuity, blurred vision, increased intraocular pressure, corneal abrasion, vitreous floaters, iridocyclitis, iritis, retinal vascular disease, vitreous hemorrhage, vitreous detachment, cataract, conjunctival hemorrhage, and punctate keratitis.

Expert Advice

Brolucizumab is administered by a qualified ophthalmologist or retina specialist.
Inform your eye doctor immediately if you experience any signs of infection, such as:
- Redness
- Pain
- Discharge from the eye
If you experience symptoms of an allergic reaction, such as:
- Hives
- Itching
- Swelling
- Difficulty breathing
Seek immediate medical attention for allergic reactions.
Inform your eye doctor if you have a history of:
- Glaucoma
- Elevated intraocular pressure (IOP)
These factors may influence treatment decisions.
Notify your eye doctor immediately if you notice any sudden changes in vision or experience flashes of light.
Inform your eye doctor if you experience:
- Eye pain
- Redness
- Sensitivity to light